• Please log in or register to access this feature.

Cancer Stem Cells

Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells†‡§

  1. Kristel Kemper1,
  2. Pramudita R. Prasetyanti1,
  3. Wim De Lau2,
  4. Hans Rodermond1,
  5. Hans Clevers2,
  6. Jan Paul Medema1,¶,*

Article first published online: 22 OCT 2012

DOI: 10.1002/stem.1233

Issue

STEM CELLS

STEM CELLS

Volume 30, Issue 11, pages 2378–2386, November 2012

Additional Information

How to Cite

Kemper, K., Prasetyanti, P. R., De Lau, W., Rodermond, H., Clevers, H. and Medema, J. P. (2012), Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells. STEM CELLS, 30: 2378–2386. doi: 10.1002/stem.1233

Author Information

  1. 1

    Laboratory for Experimental Oncology and Radiobiology, Centre for Molecular Medicine, Academic Medical Centre, Amsterdam, The Netherlands

  2. 2

    Hubrecht Institute and University Medical Center Utrecht, Utrecht, The Netherlands

  1. Telephone: +31-20-5667777; Fax: +31-20-6977192

*Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands

  1. †

    Author contributions: K.K.: conception and design, collection and/or assembly of data, data analysis and interpretation, and manuscript writing; W.D.L.: conception and design and provision of study material; P.R.P.: provision of study material, collection and/or assembly of data, and data analysis and interpretation.; H.R.: collection and/or assembly of data; H.C.: conception and design and final approval of manuscript; J.P.M.: conception and design, data analysis and interpretation, and final approval of manuscript.

  2. ‡

    Disclosure of potential conflicts of interest is found at the end of this article.

  3. §

    First published online in STEM CELLSEXPRESS August 7, 2012.

  4. Telephone: +31-20-5667777; Fax: +31-20-6977192

Publication History

  1. Issue published online: 22 OCT 2012
  2. Article first published online: 22 OCT 2012
  3. Accepted manuscript online: 11 SEP 2012 02:04PM EST
  4. Manuscript Accepted: 13 AUG 2012
  5. Manuscript Received: 12 MAY 2012

Funded by

  • AMC graduate school scholarship
  • VICI grant of NWO
  • Dutch Cancer Society. Grant Number: UvA 2009-4416

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (858K)

Additional Supporting Information may be found in the online version of this article.

FilenameFormatSizeDescription
sc-12-0454_sm_SupplFigure1.tif416KSuppl. Fig 1. Spheroid cultures were sorted for 10% highest and 10% lowest expression of LGR5 and stained for Ki67. The scale bar indicates 20 μm.
sc-12-0454_sm_SupplFigure2.tif200KSuppl. Fig 2. Spheroid cultures were sorted for 10% highest and 10% lowest expression of LGR5 (left). Purity of Lgrlow cells was checked by immediately re-running fraction of Lgr5low sorted cells (right)
sc-12-0454_sm_SupplFigure3.tif109KSuppl. Fig 3. Lentiviral construct targeting LGR5 (shB4 and shB5) led to efficient knockdown in spheroid cultures.

Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

View Full Article with Supporting Information (HTML) Get PDF (858K)